Orthopediatrics Corp Stock Insiders
| KIDS Stock | USD 17.81 0.24 1.37% |
Orthopediatrics Corp's shareholder composition spans institutional positions to insider holdings. Orthopediatrics Corp's shareholder base is 68.0% institutional and 32.64% insider. Concentrated holder bases can amplify both stability and liquidity effects.
| David Bailey President and CEO President CEO & Director |
| Mark Throdahl Chairman Executive Chairman |
Orthopediatrics |
Orthopediatrics Corp's Workforce Through the Years
A workforce review of Orthopediatrics Corp matters because hiring and staffing trends often say something about growth plans, cost discipline, and management expectations. Reported staffing levels near slightly above 600 employees reflect the current operating footprint and warrant comparison with broader business results. Reported workforce figures may vary across disclosures and time periods; aggregated or historical datasets can reflect different figures depending on reporting scope and methodology.Macro event markers
Management Team Effectiveness
KIDS has return on total asset (ROA) of -3.39% indicating that it is unable to convert its asset base into positive returns. In loss territory, with costs exceeding revenue generation. Orthopediatrics Corp also reports a return on stockholder's equity (ROE) of -11.57%, which implies that returns to shareholders were negative during the period.Insider Trading Activities
The analytical value in Orthopediatrics Corp's insider filings lies in transaction clustering, trade size, and timing relative to price movements rather than any single filing. It trades on NASDAQ in US. The business currently sits in the Healthcare sector and the Medical Devices industry.
Outstanding Bonds
Outstanding bonds linked to Orthopediatrics Corp can tell investors a great deal about how the company finances itself beyond common equity markets. Used together with earnings and cash-flow analysis, the bond stack can reveal whether leverage is a manageable tool or a developing constraint.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| Morgan Stanley Jul Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Corporate Filings
10Q | 1st of May 2026 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | |
8K | 30th of April 2026 Report filed with the SEC to announce major events that shareholders should know about | |
| 20th of April 2026 Other Reports | ||
8K | 1st of April 2026 Report filed with the SEC to announce major events that shareholders should know about | |
F4 | 17th of March 2026 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | |
| 16th of March 2026 Other Reports | ||
10K | 4th of March 2026 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | |
8K | 26th of February 2026 Report filed with the SEC to announce major events that shareholders should know about |
Holders Distribution
Institutional investors in Orthopediatrics Corp typically operate with more research capacity, technology, and trading scale than retail holders, which is why their activity can materially affect price behavior. The better interpretation comes from watching concentration, turnover, and changes in holder behavior instead of assuming institutional ownership is automatically bullish.
Workforce Comparison
Orthopediatrics Corp maintains a fourth standing in number of employees relative to competitors. The total workforce of Health Care industry is now estimated at about 15,424. Orthopediatrics Corp holds roughly 602 in number of employees claiming about 4% of equities under Health Care sector.
KIDS has Profit Margin (PM) of -16.0%. Similarly, it shows Operating Margin (OM) of -14.0%. Insider Trading History
Orthopediatrics Corp's insider log provides a timeline of management conviction alongside earnings and guidance changes. Pattern analysis matters more than any single trade. The full record tells the real story.
| Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
|---|---|---|---|---|---|
| 2026-03-01 | 0.8 | 4 | 5 | 237,865 | 58,171 |
| 2025-12-01 | 1.0 | 1 | 1 | 4,345 | 1,600 |
| 2025-03-01 | 1.0 | 5 | 5 | 290,553 | 29,032 |
| 2024-06-01 | 15.0 | 15 | 1 | 301,668 | 2,766 |
| 2023-09-01 | 0.4 | 2 | 5 | 2,635 | 6,874 |
| 2023-06-01 | 1.5 | 9 | 6 | 17,217 | 10,658 |
| 2023-03-01 | 0.6 | 6 | 10 | 145,561 | 25,231 |
| 2022-09-01 | 12.0 | 12 | 1 | 13,727,010 | 373.00 |
| 2022-06-01 | 12.0 | 12 | 1 | 23,748 | 1,595 |
| 2022-03-01 | 1.0 | 6 | 6 | 76,654 | 26,204 |
| 2021-12-01 | 4.5 | 9 | 2 | 6,844 | 4,000 |
| 2021-09-01 | 0.5833 | 7 | 12 | 3,319 | 33,063 |
| 2021-06-01 | 2.5 | 15 | 6 | 18,400 | 20,750 |
| 2021-03-01 | 0.4706 | 8 | 17 | 40,180 | 66,738 |
| 2020-09-01 | 1.0 | 1 | 1 | 670.00 | 670.00 |
| 2020-06-01 | 0.8276 | 24 | 29 | 72,030 | 54,288 |
| 2020-03-01 | 3.5 | 7 | 2 | 49,028 | 4,684 |
| 2019-09-01 | 1.0 | 1 | 1 | 134.00 | 134.00 |
| 2019-06-01 | 5.0 | 10 | 2 | 14,000 | 2,400 |
| 2018-09-01 | 0.5 | 3 | 6 | 9,721 | 20,246 |
| 2018-06-01 | 2.2 | 11 | 5 | 50,462 | 131,557 |
| 2017-12-01 | 0.2692 | 14 | 52 | 16,191,665 | 19,047,108 |
Notable Stakeholders
An Orthopediatrics Corp stakeholder is any individual or group with an interest in the outcome of the business, which is why stakeholder analysis can reveal who may influence strategy and oversight. In practice, stakeholder review supports awareness of the people and incentives that may be shaping key decisions behind the scenes.
| David Bailey | President CEO & Director | Profile | |
| Mark Throdahl | Executive Chairman | Profile | |
| Joseph Hauser | President of Trauma, Deformity Correction & OPSB | Profile | |
| Kevin CHE | President of Enabling Technologies | Profile | |
| Gregory Odle | President of Scoliosis | Profile | |
| Fred Hite | CFO, Principal Financial & Accounting Officer, COO and Director | Profile | |
| Daniel Gerritzen | Executive VP of Legal, General Counsel & Secretary | Profile | |
| Ray Garrison | Senior Vice President of Quality & Regulatory and Clinical | Profile | |
| Mark Karshner | Senior Vice President of International Sales | Profile |
Management Information & Data Sources
Orthopediatrics Corp is a small-cap company across Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care. Insider transaction activity tracks recent buying and selling by executives and directors. Clusters of insider purchases can signal internal confidence, though context and timing matter. CEO is David Bailey with 602 employees and 9 reported executives.
Orthopediatrics Corp values are built from periodic company reporting and market reference feeds, with reporting definitions aligned before display. Analyst inputs may be included when coverage is available. Insider and management fields are mapped from published filings and company disclosures.
Editorial review and methodology oversight provided by: Gabriel Shpitalnik, Member of Macroaxis Editorial Board
Workforce Efficiency and Productivity
Workforce metrics tied to Orthopediatrics Corp offer a useful way to test whether headcount and economic output are moving in a productive direction. When applied, manpower metrics highlight whether growth is being supported by better productivity or by heavier staffing costs.
Orthopediatrics Corp Manpower Efficiency
Return on Orthopediatrics Corp Manpower
| Revenue Per Employee | 392.6K | |
| Revenue Per Executive | 26.3M | |
| Net Loss Per Employee | 65.9K | |
| Net Loss Per Executive | 4.4M | |
| Working Capital Per Employee | 349.2K | |
| Working Capital Per Executive | 23.4M |
Additional Tools for Orthopediatrics Stock Analysis
Bollinger BandsUse Bollinger Bands indicator to analyze target price for a given investing horizonMy Watchlist AnalysisAnalyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you likeBond AnalysisEvaluate and analyze corporate bonds as a potential investment for your portfolios.Stocks DirectoryFind actively traded stocks across global marketsEquity SearchSearch for actively traded equities including funds and ETFs from over 30 global marketsPortfolio ManagerState of the art Portfolio Manager to monitor and improve performance of your invested capitalFunds ScreenerFind actively-traded funds from around the world traded on over 30 global exchangesPortfolio DiagnosticsUse generated alerts and portfolio events aggregator to diagnose current holdingsHeadlines TimelineStay connected to all market stories and filter out noise. Drill down to analyze hype elasticity